尼古拉斯·弗朗西斯

2023年2月13日

æsir啟動重塑生物技術取得了波通過提高7.1美元增加其價值1美元的種子資金,創建一個新的全國紀錄的8.1美元。這成就了可能由於Acme資本的支持,以及頂級投資者尼古拉斯·弗朗西斯的創始人團結,每Falholt和查找項目,其中包括尊敬企業家湯米Ahlers和Nicolaj Reffstrup。啟動開發訪問自動化解決方案,幫助領導人在食品、農業和生物製劑數字化研究和全球合作。有額外的資金,重塑生物技術正尋求擴大其產品已經提供,其創新的分析平台更上一層樓。Y Combinator 2021班的一員,重塑生物技術允許公司容易數字化微生物學實驗,幾乎在全球範圍內進行合作。傳統上,實驗室自動化極其昂貴,難以實現。重塑提供負擔得起的機器人工具利用係統工程、機電一體化、雲計算、machine-learning-based數據分析和生物技術應用的深入了解。機器人是垂直整合在硬件、軟件和微生物學準確捕獲數據,而消除冗餘進程。重塑目前20個客戶服務包括研究人員、科學家、實驗室技術,和CXOs在農業與食品微生物學、材料開發、工業生物技術等等。其技術和服務的力量導致了100%的客戶保留和300%的同比增長。 “Biotech is the most important industry of the 21st century. For it to flourish in the future, we have to make the discovery process more accessible and affordable. Automation at scale is critical to making that a reality,” said Reshape Biotech founder & CEO Carl-Emil Grøn . “We are ‘reshaping’ manual processes that have remained largely unchanged over the last 100 years. Our technology is helping R&D labs troubleshoot in real time with production sites located tens of thousand miles away and letting researchers check results from home, allowing remote work to prosper in lab environments. It’s an efficient approach that better fits the world we live in today.” The Reshape platform creates a new R&D infrastructure for leaders in food, agriculture and biology, enabling digitized research that can be shared to benefit scientists everywhere, regardless of physical lab location. The distributed platform with connected lab equipment empowers scientists and technicians to conduct research 1,000X more rapidly than today. Since 2021, Reshape has grown its robotic fleet from one to 110, experienced 10X revenue growth, and facilitated groundbreaking scientific breakthroughs. “Digitizing laborious processes in research and development for food and biotech industries can lead to healthier societies for people and our planet,” said Tang-Jespersen . “Reshape challenges the status quo of the last century of microbiology experimentation with a cost-efficient product that allows for much higher volume experiments, more meaningful data points, and faster results. This technology has the potential to change the integrity of our food supply, biotech, and more.” Headquartered in Copenhagen, Reshape currently distributes equipment across Europe and the U.S. In the near future, the company plans to open a location in North America and expand development, application science and sales efforts to scale its robotic fleet in the coming years.